Literature DB >> 9732193

Extracorporeal shock wave lithotripsy for lower caliceal calculi.

B Küpeli1, H Biri, Z Sinik, K Karaca, A Tuncayengin, U Karaoğlan, I Bozkirli.   

Abstract

OBJECTIVE: The aim of the study is to determine the effectiveness of extracorporeal shock wave lithotripsy (ESWL) therapy for isolated lower caliceal calculi. PATIENTS AND METHODS: We analyzed 165 patients who were treated with the Siemens Lithostar Plus on an outpatient basis between March 1993 and August 1997. The age of patients ranged from 17 to 70 (mean 39.11) years. The stone size varied from 4 to 42 mm, and patients who had stones larger than 21 mm had a double-J stent inserted prior to treatment.
RESULTS: The overall stone-free rate at 3 months was 53.33%; whereas it was 61.79, 48.27, and 27.27% according to the stone size, </=10, 11-20 and >/=21 mm, respectively. Complications were rare, including 2 pyelonephritis, 2 subcapsular hematoma formation, 24 renal colics and 8 stone streets, which were managed by ureteral stenting or additional ESWL and resulted in complete stone clearance.
CONCLUSION: ESWL therapy is a reasonable and effective method for small lower caliceal stones, but due to its relatively low stone-free and high complication rates, percutaneous nephrolithotripsy or open surgery should be considered for stones larger than 21 mm.

Entities:  

Mesh:

Year:  1998        PMID: 9732193     DOI: 10.1159/000019713

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  10 in total

1.  Prediction of outcomes of renal stones from stone characteristics after shock-wave lithotripsy: is unenhanced helical computed tomography better?

Authors:  Husnu Tokgoz
Journal:  Eur Radiol       Date:  2005-08-16       Impact factor: 5.315

2.  The impact of radiological anatomy in clearance of lower caliceal stones after shock wave lithotripsy.

Authors:  Mustafa Ozgür Tan; Lokman Irkilata; Ilker Sen; Metin Onaran; Bora Küpeli; Ustünol Karaoğlan; Ibrahim Bozkirli
Journal:  Urol Res       Date:  2007-04-20

3.  Percutaneous nephrolithotomy for the treatment of lower pole renal calculi.

Authors:  Reem Al-Bareeq; John D Denstedt
Journal:  Can Urol Assoc J       Date:  2008-12       Impact factor: 1.862

4.  Comparative Study of Lithotripsy and PCNL for 11-15 mm Lower Caliceal Calculi In Community Health Hospital.

Authors:  Narendra Haribhau Wankhade; Jayant Gadekar; Babaji B Shinde; Julie Anand Tatte
Journal:  J Clin Diagn Res       Date:  2014-06-20

5.  Value of ultrasonography and helical computed tomography in the diagnosis of stone-free patients after extracorporeal shock wave lithotripsy (USG and helical CT after SWL).

Authors:  Bora Küpeli; Serhat Gürocak; Lütfi Tunç; Cağri Senocak; Ustünol Karaoğlan; Ibrahim Bozkirli
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

6.  Alternative management of complex renal stones.

Authors:  Millie Pevzner; Brian C Stisser; Jordan Luskin; Jeffrey C Yeamans; Marina Cheng-Lucey; John J Pahira
Journal:  Int Urol Nephrol       Date:  2011-01-12       Impact factor: 2.370

7.  Diuresis and inversion therapy to improve clearance of lower caliceal stones after shock wave lithotripsy: A prospective, randomized, controlled, clinical study.

Authors:  Abul-Fotouh Ahmed; Essam Shalaby; Aref Maarouf; Yasser Badran; Mahmoud Eladl; Ammar Ghobish
Journal:  Indian J Urol       Date:  2015 Apr-Jun

Review 8.  [Ureteral stricture after extracorporeal shock wave lithotripsy. Case report and overview of the spectrum of rare side effects of modern ESWL treatment].

Authors:  F Finter; L Rinnab; J Simon; B Volkmer; R Hautmann; R Kuefer
Journal:  Urologe A       Date:  2007-07       Impact factor: 0.803

9.  Management of 1-2 cm renal stones.

Authors:  Aneesh Srivastava; Saurabh S Chipde
Journal:  Indian J Urol       Date:  2013-07

10.  Selected examples of complications after minimally invasive treatment for urolithiasis.

Authors:  Waldemar Różański; Leszek Klimek; Marek Lipiński; Rafał Kliś
Journal:  Cent European J Urol       Date:  2012-06-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.